Platform reduces procedure time by allowing simultaneous MR and PET
MISSISSAUGA, ON, Feb. 8, 2012 /CNW/ - Scientists at the Lawson Health Research Institute will be the first in
Canada to use the Biograph mMR magnetic resonance imaging/ positron
emission tomography/ (MR/PET) system to study treatable mechanisms of
brain damage caused by stroke and Alzheimer's disease. Lawson
researchers predict that this new technology will soon aid clinicians
in determining the most beneficial patient therapies and in reducing
the burden of stroke and dementia among Canadians.
Siemens is the only vendor in the world to provide a synchronous MR/PET
solution with the Biograph mMR. Simultaneous acquisition of MR and PET
images reduces overall procedure time by providing both data sets in a
single exam, thereby significantly reducing exam duration compared to
traditional sequential imaging. Faster procedure times improve the
patient experience and enable faster delivery of images for clinician
"Siemens and Lawson have been research partners for 24 years, working
together to enhance the lives of Canadians," says Jim Graziadei, senior
vice president, Siemens Healthcare. "Integrating these two powerful
modalities into one simultaneous whole-body system represents a
breakthrough innovation. Technologies such as the Biograph mMR provide
our customers with solutions to improve clinical workflow, and as a
result, improve patient care in a sustainable, cost-effective manner."
With its simultaneous data acquisition, the Biograph mMR is expected to
be particularly valuable in the identification of neurological,
oncological and cardiac conditions of disease and in supporting therapy
planning. The Biograph mMR also opens new opportunities for research,
such as the development of new biomarkers and therapeutic approaches.
"MR/PET scanners are among the most exciting and talked about
developments in radiology and nuclear medicine and represent the next
generation of imaging technology," states Dr. Frank Prato, Imaging
Program Leader at Lawson and Physicist Chief at St. Joseph's Hospital.
"The applications for MR/PET are limitless. The scanner will be used
by researchers in London to help improve diagnosis and treatment of
Canada's major health challenges, such as cardiovascular disease,
neurological diseases, mental health, and cancer."
Siemens Healthcare was awarded the Biograph mMR contract from the Lawson
Health Research Institute in September of 2011. Platform installation
began February 7, with full commissioning expected by summer 2012. A
symposium exploring several mMR research programs is planned for late
For more information: http://www.siemens.com/press/healthcare/Biograph-mMR
The herein mentioned product is not commercially available in all
countries. Due to regulatory reasons its future availability in any
country cannot be guaranteed. Please contact your local Siemens
organization for further details.
About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to
the healthcare industry and a trendsetter in medical imaging,
laboratory diagnostics, medical information technology and hearing
aids. Siemens offers its customers products and solutions for the
entire range of patient care from a single source - from prevention and
early detection to diagnosis, and on to treatment and aftercare. By
optimizing clinical workflows for the most common diseases, Siemens
also makes healthcare faster, better and more cost-effective. Siemens
Healthcare employs some 51,000 employees worldwide and operates around
the world. In fiscal year 2011 (to September 30), the Sector posted
revenue of 12.5 billion euros and profit of around 1.3 billion euros.
For further information please visit: http://www.siemens.com/healthcare
About Siemens in Canada
For 100 years the innovative ideas from Siemens have helped make Canada
a better place. From the Atlantic to Pacific oceans, more than 4,400
employees in Canada work together to provide answers that last in the
fields of industry, energy and healthcare, as well as deliver
infrastructure solutions for cities. Since it was federally chartered
in August of 1912, Siemens has stood for technical achievements,
innovation, quality and reliability. Sales for Siemens in Canada in
fiscal 2011 (ended September 30), were $3.0 billion CAD. The company
has 61 offices and 13 manufacturing/assembly facilities across Canada.
Further information is available at www.siemens.ca
This press release may contain forward-looking statements based on the
beliefs of the management of Siemens Canada Limited and its affiliates.
The words "anticipate," "believe," "estimate," "forecast," "expect,"
"intend," "plan," "should," and "project," are used to identify
forward-looking statements. Such statements reflect the management's
current views with respect to future events and are subject to risks
and uncertainties. Many factors could cause the actual results to be
materially different, among others, changes in general economic and
business conditions, changes in currency exchange rate and interest
rates, introduction of competing products, lack of acceptance of new
products or services and changes in business strategy. Actual results
may vary materially from those projected here. Siemens Canada Limited
and its affiliates do not intend or assume any obligation to update
these forward-looking statements.
SOURCE Siemens Healthcare
For further information:
Vice-President, Communications and Strategy